Published in Healthcare Finance, Tax and Law Weekly, February 7th, 2007
This trend article about Pfizer, U.S., is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations," have been published. According to a study from the United States, "Glucokinase (GK) has several known polymorphic activating mutations that increase the enzyme activity by enhancing glucose binding affinity and/or by alleviating the inhibition of glucokinase regulatory protein (GKRP), a key...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.